These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 80634)

  • 21. Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension.
    Waeber B; Brunner HR; Wauters JP; Gavras H
    Adv Nephrol Necker Hosp; 1981; 10():111-33. PubMed ID: 6267906
    [No Abstract]   [Full Text] [Related]  

  • 22. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].
    Overlack A; Stumpe KO; Heck I; Krück F
    Dtsch Med Wochenschr; 1980 Apr; 105(15):505-9. PubMed ID: 6244920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
    Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
    Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term treatment of hypertension in man by an orally active angiotensin-converting enzyme inhibitor.
    Brunner HR; Gavras H; Turini GA; Waeber B; Cappuis P; McKinstry DN
    Clin Sci Mol Med Suppl; 1978 Dec; 4():293s-295s. PubMed ID: 215374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indomethacin inhibits the antihypertensive effect of captopril, SQ 14225, in low renin hypertension.
    Abe K; Itoh T; Imai Y; Sato M; Goto T; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1980 Sep; 132(1):117-8. PubMed ID: 7010681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the oral converting enzyme inhibitor, SQ 14225, in a model of low cardiac output in dogs.
    Freeman RH; Davis JO; Williams GM; DeForrest JM; Seymour AA; Rowe BP
    Circ Res; 1979 Oct; 45(4):540-5. PubMed ID: 225056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension.
    Brunner HR; Gavras H; Waeber B; Turini GA; McKinstry DN; Vukovich RA; Gavras I
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):205S-211S. PubMed ID: 223614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Captopril and salt subtraction to treat "uncontrollable" hypertension in haemodialysis patients.
    Wauters JP; Waeber B; Brunner HR; Turini GA; Guignard JP; Gavras H
    Proc Eur Dial Transplant Assoc; 1979; 16():610-7. PubMed ID: 232915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long term treatment of resistant hypertension with captopril (author's transl)].
    Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
    Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of antihypertensive therapy on renal function in nephrogenic hypertension].
    Figarov IG; Dzhavad-Zade SM
    Urol Nefrol (Mosk); 1998; (3):27-9. PubMed ID: 9644986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of an angiotensin converting enzyme inhibitor on psychosocial hypertension in mice.
    Henry JP; Vander AJ; Stephens PM
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():153s-155s. PubMed ID: 232019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Converting enzyme inhibition with captopril in patients with primary hyperaldosteronism.
    Luderer JR; Demers LM; Harrison TS; Hayes AH
    Clin Pharmacol Ther; 1982 Mar; 31(3):305-11. PubMed ID: 6277545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
    Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
    Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of hypertensive crisis with captopril].
    Biollaz J; Waeber B; Turini GA; Schaller MD; Brunner HR
    Schweiz Med Wochenschr; 1983 Dec; 113(52):2006-7. PubMed ID: 6364338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A 100-year perspective on renal function and hypertension. Anti-renin therapy has made hypertensive renal failure a rarity].
    Bergström G; Herlitz H; Himmelmann A; Ljungman S; Aurell M
    Lakartidningen; 1999 Nov; 96(47):5209-14. PubMed ID: 10608112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Captopril (SQ 14,225) (D-3-mercapto-2-methylpropranoyl-L-proline): a novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent.
    Rubin B; Antonaccio MJ; Horovitz ZP
    Prog Cardiovasc Dis; 1978; 21(3):183-94. PubMed ID: 214818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.